Medicare Prescription Drug Price Negotiation Act of 2017
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Jan 4, 2017)
Medicare Prescription Drug Price Negotiation Act of 2017
This bill amends title XVIII (Medicare) of the Social Security Act to require the Centers for Medicare & Medicaid Services (CMS) to negotiate with pharmaceutical companies regarding prices for drugs covered under the Medicare prescription drug benefit. Current law prohibits CMS from doing so.
What just happenedJan 25, 2017
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseJan 4, 2017
- Jan 25, 2017Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Jan 13, 2017Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Jan 4, 2017IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Ways and Means Committee - Jan 4, 2017IntroReferralH11100-A
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Jan 4, 2017IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Energy and Commerce Committee - Jan 4, 2017IntroReferralIntro-H
Introduced in House
- Jan 4, 2017IntroReferral1000
Introduced in House